List of Vendor Companies in Ireland - 25

At Altratech, we are moving serology and the monitoring of viral contagious diseases out of the laboratory to the point-of-care and community clinics. We are a team of twenty scientists and engineers, including nine PhDs, from cross-functional backgrounds of molecular biology, organic and synthetic chemistry, microfluidics, engineering and CMOS semiconductor technologies. With over 200 years of combined experience, our vision is to create portable high-performance diagnostics which will enable the next generation of decentralised connected healthcare and wellbeing.

AnaBio Technologies is a biotechnology company based in Ireland that specializes in microencapsulation technologies. The company enhances the delivery and effectiveness of sensitive bioactive ingredients, focusing on precision nutrition solutions for both human and animal health. Founded by Dr. Sinéad Bleiel, AnaBio originated from her PhD research and has grown to employ around 20–27 staff, generating reported revenue of $6.4 million. AnaBio offers a range of services, including microencapsulation technology that protects ingredients like probiotics and vitamins from degradation. They develop customized formulations for controlled release, optimizing effectiveness in dietary supplements, infant nutrition, and sports recovery. Their flagship product line includes encapsulated probiotics designed to improve gut health outcomes. Additionally, AnaBio is expanding its offerings to include specialized microencapsulated ingredients for livestock and pet health. The company serves global clients across the food, pharmaceutical, and animal nutrition industries, emphasizing scientific innovation and tailored solutions.

Aran Biomedical is now part of Integer. Visit www.integer.net to learn more. Aran Biomedical is a trusted partner in design, development and manufacture of biomaterial focused medical implant products. We provide expertise in medical textiles, biomaterial covering and coating of implants, as well as absorbable implants. We have a proven track record in innovative design and quality-assured manufacturing, delivering solutions for a range of different markets and medical applications. Aran Biomedical enables you to supply next generation products to clinicians and their patients. • Cardiovascular • General Surgery • Orthopaedics Aran Biomedical offers a complete solution to medical device companies who seek a contract partner to help realise their product development needs, from concept to finished packaged medical implants. From concept design and development through to the production transfer of approved medical devices in a quality assured environment, Aran Biomedical is committed to providing an unparalleled degree of service. Dedicated consultation, project management, and technical resources are provided throughout to ensure clients' expectations are surpassed in taking quality products to market.

At Biostór Ireland Ltd, our success is driven by a culture of collaboration, innovation and determination. We believe in progressive thinking, in challenging ourselves and each other, with the goal of enhancing patient outcomes and patient lives. Our mission is to serve our customers with the highest quality, ethics and practices, and to provide best in class customer service & client experience. We are a Bio repository for temperature critical storage of bio materials & a choice of controlled storage conditions down to -196°C (Liquid Nitrogen Vapour) and a range of validated cold-chain distribution services. Biostór is validated to GMP standards. The Quality Management System is designed to comply with applicable EU & US regulations and international standards: ISO 13485:2003. The company has been audited and approved by major US FDA regulated multinational pharmaceutical companies. Our operations are subject to stringent regulation as set down by EU Tissues & Cells Directives. In March 2008 the facility was inspected and accredited by the Irish Medicines Board (IMB) as a Tissue Establishment for the GTP storage and distribution of Human Tissues and Cells for human application throughout the 27 member countries of the EU. Biostór can cater for a wide range of sample types: Active Pharmaceutical Ingredients (APIs) and Finished Products, Clinical Trial Samples, Donor Materials, Plasma, Serum and Body Fluids, Human Tissues and Cell Products i.e., Bone Marrow, Cord Blood & Reproductive Cells. The company currently maintains the national archive of Bone Marrow, Peripheral Stem Cells and Donor Lymphocytes for the country's main cancer hospital. Biostór Ireland is located at Rosslare Harbour, Co. Wexford, 2km from the international Europort with fast road/ferry transit times to UK & Europe, 2 hours by road from Dublin/Cork airports with overnight courier service to all European centres. The store has a current capacity for 5 million biological samples.

Cara Partners is a pharmaceutical manufacturing company that specializes in producing a standardised extract of Ginkgo Biloba, an Active Pharmaceutical Ingredient (API), in County Cork, Ireland.

Deciphex is building a global network of AI empowered pathologists, ensuring accessible, innovative pathology services that improve patient outcomes. The pathology industry is beset with increasing caseload and diagnostic complexity, against a globally declining number of pathologists to service the workload. We believe that digital pathology combined with computer aided diagnostic tools will help make pathologists work more efficiently in the future, and offers a solution to the pending crisis in supply/demand in pathology services.

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.

We are a research-driven company that specialises in the development, manufacture and supply of a broad range of High Potency Oral Solid Dose (OSD) Human & Veterinary speciality products. Since 2006, we have built a reputation as an innovative company specialising in developing and manufacturing of film-coated tablets, soft-gel capsules, and powder or liquid-filled hard-shell capsules. Our work, which focused on successfully producing cancer chemotherapy drugs, allowed us to create strong partnerships with leading pharmaceutical companies, thus making our founders' vision a reality. In 2015, our successful track record and reputation for industry excellence prompted the acquisition of Eirgen Pharma by the OPKO Health family of companies. Becoming a part of OPKO Health has allowed Eirgen Pharma to invest further in our facilities and our people, increasing development and manufacturing capabilities. Eirgen now serves patients in more than 60 countries worldwide, including major markets such as the USA, Europe, Japan, Canada, Australia, the Middle East and Africa. Nowadays, at Eirgen Pharma's centre of excellence in Waterford, Ireland, we simplify the journey of getting your product to market by providing full turnkey CDMO services for the development, manufacture and packaging of high potency oral dose medicines for both human and veterinary use. Eirgen also holds the production rights for numerous OSD products and has the capacity to manufacture each of these products at scale.

ERS Genomics was formed to commercialise the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner and Nobel Prize-winner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use. CRISPR-Cas9 is a revolutionary new genome editing technology, which offers significant advantages in speed, efficiency and cost over earlier genome editing methods. Our team has decades of experience in the field of genome editing and its application, in business development and licensing, licensing preclinical and clinical stage therapeutic products and drug delivery technologies, genome editing technologies as well as overseeing research and development. To learn more about acquiring your license, contact us today.

Keltic Pharma is based in a world leading laboratory in Glasgow with our highly skilled team of industrial scientists and leading academics. We work alongside commercial partners and universities to deploy novel innovative technologies in the pursuit of next generation drugs for unmet clinical needs.

Luminate Medical is a healthcare technology company that builds devices to make cancer care better for patients by preventing side effects and making at-home treatments a possibility. Based in Galway, Ireland, Luminate is pioneering the development of Lily, a device to prevent chemotherapy induced hair loss in a comfortable and portable way, Lilac, the world's first preventative treatment for peripheral neuropathy, and further pipeline projects enabling remote cancer care. Luminate is a VC-backed startup funded by Y Combinator (S21) with multiple successful grant and investment rounds to date.

Metabolomic Diagnostics is a deep-tech company specialised in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory. Metabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy, her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.

Established in 2009, MyBio is a premium supplier of research products, technology, and expertise. We're at the forefront of innovation, enabling the science that's changing lives for the better. Our clients include a range of life scientists based in research laboratories from a variety of sectors. For Academia As scientists ourselves, we understand the challenges that are faced by researchers every day. From needing that all important reagent as quickly as possible, to having to keep an eye on budget – we can help every step of the way too. Quality & Support Our partners are carefully selected, meaning that the products they produce are of the highest quality. As scientists, we only supply tools and equipment that we would use ourselves. Time is of the essence for a busy researcher, therefore we offer full troubleshooting support for when things are not quite going to plan. For Pharma We are an established supplier of custom products for the pharmaceutical industry, with a team of dedicated scientists experienced in the drug discovery and development process. Using our expertise, we are able to work closely with pharmaceutical companies confidentially, tailoring solutions to their unique problems through our well-established ties with our suppliers. We are able to provide our clients with truly customized products that allow for the efficient conversion of potential API leads into candidates and through to established therapeutic drugs. For Suppliers We are always looking to evolve alongside new partners, and have a proud record of delivering strong growth for our suppliers, owing to our knowledge of our customers’ challenges, and our experience of the market on a national level. MyBio are innovative and ambitious, and we are proud of our reputation as one of Ireland’s most trusted suppliers, helping manufacturers penetrate the market and deliver their trusted innovations to laboratories nationwide.

A multi-award winning Irish company innovating in women's health. Nua Surgical was developed out of BioInnovate Ireland and is dedicated to innovating in Women's Health. The team are currently pursuing solutions to unmet clinical needs in obstetric surgery. In 2018, the founding team secured a 2 year Research and Commercialisation Grant from Enterprise Ireland to develop the SteriCISION C-Section Retractor at the University of Galway. Brief Overview of Achievements: 𝟮𝟬𝟭𝟴 - Our founding team were awarded an Enterprise Ireland Commercialisation Fund to bring the project from early stage concept to commercialisation.  This was based at the University of Galway. 𝟮𝟬𝟭𝟵 - Nua Surgical was chosen as one of seven start-ups between Ireland and the U.S. to participate in the Blackstone-backed accelerator 'LaunchPad Lift' powered by Techstars. - Our CEO was named 'Best Senior Entrepreneur' at the EIT Health Alumni Needs-Led Innovation Showcase in Lisbon, Portugal. 𝟮𝟬𝟮𝟬 - One of 16 UK and Ireland Start-ups to be awarded €40,000 through the EIT Health Headstart Programme. - One of 15 winners for the national HIHI Healthcare Innovation Call 2020.   - Winner of the InterTrade Ireland Seedcorn Competition, securing €100,000.   𝟮𝟬𝟮𝟭 - Winners of the Global Healthy Mom and Baby Innovation Competition 2.0, run by Parkview Health and MATTER (USA).  𝟮𝟬𝟮𝟮 - Won MedTech category of the 'Global Tech For Good' Competition run by Empact Ventures, Hays and the NIHR. - Winner of the MedTech Category at the National Start-Up Awards, followed by overall Grand-Prix Winner at the famous Dublin City Hall ceremony.  𝟮𝟬𝟮𝟯 - The only non-US company to participate in Cohort 15 of the prestigious Texas Medical Center HealthTech Accelerator. - 1 of 8 Irish finalists for the KPMG Global Tech Innovation Awards. - 'Emerging MedTech Company of the Year' at the prestigious Irish MedTech Awards. - Double winners at the 2023 National HealthTech Innovation Awards.

ProVerum Medical is a Dublin-based medical device company founded in 2016. The company specializes in minimally invasive solutions for benign prostatic hyperplasia (BPH), focusing on developing technologies that address lower urinary tract symptoms caused by prostate enlargement. Their primary product, the ProVee System, features a nitinol expander designed to reshape the enlarged prostate and alleviate urinary obstruction. This system is deployed through a low-profile, flexible delivery method that integrates imaging, making it compatible with standard office-based endoscopes. The procedure is minimally invasive and can be performed under local anesthesia, offering a patient-friendly alternative to traditional surgery. ProVerum holds eight patents, including one granted in 2023 for a device that deploys expandable implants targeting BPH and urinary system disorders. The company has raised a total of $38.58 million in funding, including a €30 million Series A round in 2022. ProVerum is currently conducting the ProVIDE study to evaluate the safety and efficacy of the ProVee system, which completed enrollment in March 2024.

SOSV is a global venture capital firm that operates early stage startup development programs. SOSV’s programs are focused on revolutionary deep technology that promises the betterment of humanity and the planet. The firm’s strategy is to invest in a small number of highly promising startups and use its deeply resourced programs to accelerate product development, acquire customers, and scale. SOSV companies consistently raise funding rounds led by top tier investors. SOSV joins seed, Series A, and later rounds while providing founders with ongoing support and community. As of January 2024, SOSV had more than 1,000 portfolio companies and $1.5 billion in assets under management. SOSV’s programs include hard tech-oriented HAX and life-science driven IndieBio. Both offer deep technical and scientific expertise on-site as well as well-equipped lab and fabrication facilities and supply chain access. Among the top companies in SOSV’s portfolio are NotCo, Upside Foods, Unspun, Opentrons, Mycoworks, and Prime Roots. SOSV releases the annual Human Health 100, a list of the firm’s top human health investments in areas ranging from assistive robotics to therapeutics and diagnostics. SOSV also publishes the annual Climate Tech 100, a list of the firm’s top climate-focused investments working on solutions to climate change across five sectors: food, manufacturing, transport, energy, and building systems.

Rockfield Medical Devices is an innovative SME developing feed delivery systems which will transform the mobility and quality of life of those on tube feeding.

SeqBiome is a world leading microbiome contract research company, providing first in class technical and scientific services to researchers in leading companies in the Pharma, Food, and Nutrition industries and to academic researchers in top Universities. SeqBiome measures, analyzes, and interprets the microbiome using state-of-the-art tools, partnering with industry and academia to offer custom sequencing and bioinformatics services. We are committed to helping our customers derive actionable insights from their projects. SeqBiome offers an end-to-end Microbiome analysis service for our customers. We add most value to our customers by being involved early in their study and we can assist them with Statistical Study Design, Sample Processing, Metagenomic Sequencing, Compositional and Functional Microbiome Analysis, Biostatistical and Bioinformatic Analysis, and Publication/Patent Ready Outputs.

Serosep are Ireland's leading Microbiology Diagnostics specialists. We are proud of our position as the innovative, specialist partner of choice for customers in Ireland, the UK, the European and world markets. Our loyal customer network of individuals & Laboratory's enjoy and depend on the many benefits of our easy to use Diagnostic product line. For over 20 years we have built a strong competitive position based on responsive customer service, laboratory operations and diagnostics knowledge with a committed and specialist team. We are committed to continuously improving our own operations, the design of our diagnostic products and the standards of best practice in our activities across the markets in which we supply and service.

Spinal Stabilization Technologies, LTD ("SST") is a commercial-ready U.S. medical device company with a manufacturing facility in Ireland through its Irish subsidiary. The Company has developed a new surgical device and procedure for restoring the nucleus pulposus of the lumbar spine. The company has extensive worldwide intellectual property. The products and techniques SST develops are based on the philosophy that less invasive surgery may be associated with better clinical outcomes. These products and techniques could improve the lives of many patients that have limited options for treating their back pain. The company is focused on evidence-based medicine, has completed three trials, is currently conducting a clinical trial and is in the planning phase of two additional clinical trials.

Trinity Biotech specialises in the development, manufacture and marketing of diagnostic test kits and equipment. The quality and efficacy of our products is essential to ensure clinicians and patients are provided with a reliable, safe and robust method of diagnosis. It’s essential that we are always cognisant that a patient may receive a life changing diagnosis from one of our products. Trinity Biotech is a company which is made up of a wide range of people from different backgrounds and experience. Our goal is to have a friendly, inclusive and fun place to work which also supports the needs of our business. Working at Trinity Biotech means working on a range of items which provides great experience and keeps our roles interesting, challenging and rewarding. Our size makes us an organisation which is large enough to ensure there is a wide range of activities, projects and day to day variety.

Uniphar is a diversified healthcare services organisation with activities in Ireland, UK, Europe, the USA and APAC.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in hundreds of countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD’s website at www.utahmed.com.

The company develops advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology, interventional radiology and vascular surgery.

Today one of Europe’s premier facilities, Weatherbys Scientific in Ireland has been involved in animal parentage testing since 1985. The laboratory has been accredited with CSPro certification by Illumina, has ISO 17025 certification and is also accredited by The International Committee for Animal Recording (ICAR). We are continuously expanding our range of services to match the needs of the industry. Initially the laboratory offered a blood typing service to confirm pedigrees, as part of foal registration. Then, in 1990, the laboratory extended this to the non-thoroughbred sector as part of the registration of foals for the Irish Horse Board. The laboratory introduced DNA technology at the beginning of this century. This superseded blood-typing and provided further opportunities to confirm pedigrees of other animal species such as cattle, sheep, dogs and cats. The Laboratory is now offering its services to the Irish and British livestock industries. It is recognised by the International Society of Animal Genetics (ISAG) as one of the leading laboratories in the world in pedigree verification. It is the only such laboratory in Ireland recognised by ISAG to have achieved the necessary standards in multi-species parentage testing. In January 2011 the laboratory introduced cattle genomic testing. This enhances the prediction values for the estimated breeding index (EBI) of individual breeding stock in the livestock industry. We are now genotyping with the bovine IDB V3, 54K and 770K (HD) SNP chips to increase reliability of genetic predictions in the livestock industry